People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Imago BioSciences, Inc. | — | Biotech / Pharma | Series C | $137.5M | $2.7B | 2014 |
Laura G. Eichorn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Laura G. Eichorn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick J. Heron | 1 | 7 |
| Dina Chaya Moghrabi | 1 | 2 |
| Hugh Y. Rienhoff, Jr. | 1 | 2 |
| DENNIS J HENNER | 1 | 2 |
| Robert Chaya Baltera | 1 | 1 |
| Harish Chaya Soundararajan | 1 | 1 |
| Alan Chaya Sachs | 1 | 1 |
| Alan G. Sachs | 1 | 1 |
| Hugh Y. Rienhoff | 1 | 1 |
| Dennis G. Henner | 1 | 1 |
| Patrick G. Heron | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.